Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors
作者:Angela G. Koryakova、Yan A. Ivanenkov、Elena A. Ryzhova、Elena A. Bulanova、Ruben N. Karapetian、Olga V. Mikitas、Eugeny A. Katrukha、Vasily I. Kazey、Ilya Okun、Dmitry V. Kravchenko、Yan V. Lavrovsky、Oleg M. Korzinov、Alexandre V. Ivachtchenko
DOI:10.1016/j.bmcl.2007.11.121
日期:2008.6
heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamide inhibitors of GSK-3beta kinase are described. The inhibitory activity of the synthesized compounds is highly dependent on the character of substituents in the phenyl ring and the nature of terminal heterocyclic fragment of the core molecular scaffold. The most potent compounds from this series contain 3,4-di-methyl
一系列新型的GSK-3beta芳基和杂芳基取代的N- [3-(4-苯基哌嗪-1-基)丙基] -1,2,4-恶二唑-5-羧酰胺抑制剂的合成,生物学评估和SAR依赖性描述了激酶。合成化合物的抑制活性高度依赖于苯环中取代基的特性以及核心分子支架的末端杂环片段的特性。该系列中最有效的化合物在苯环和与1,2,4-恶二唑杂环相连的3-吡啶片段内包含3,4-二甲基或2-甲氧基取代基。这些化合物选择性抑制GSK-3beta激酶,其IC(50)值分别为0.35和0.41 microM。